Treatment follow-up and response
| . | According to clinical trial protocol . | Hypothetically according to iwCLL general practice guidelines . | P value . |
|---|---|---|---|
| Number of doctor’s visits, median (range) | 18 (3-34) | 10 (1-18) | <.001 |
| Number of blood tests, median (range) | 30 (3-73) | 18 (1-45) | <.001 |
| Number of CT examinations, median (range) | 10 (2-17) | 0 (0-0) | <.001 |
| Number of bone marrow biopsies, median (range) | 1 (0-4) | 0 (0-0) | ns |
| Overall response rate | 90% | 93% | ns |
| . | According to clinical trial protocol . | Hypothetically according to iwCLL general practice guidelines . | P value . |
|---|---|---|---|
| Number of doctor’s visits, median (range) | 18 (3-34) | 10 (1-18) | <.001 |
| Number of blood tests, median (range) | 30 (3-73) | 18 (1-45) | <.001 |
| Number of CT examinations, median (range) | 10 (2-17) | 0 (0-0) | <.001 |
| Number of bone marrow biopsies, median (range) | 1 (0-4) | 0 (0-0) | ns |
| Overall response rate | 90% | 93% | ns |
ns, not significant.